HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stents vs. pills: can opening blocked arteries save more hearts?
Disease control Not yet recruitingThis study looks at 654 people with heart failure and a weak heart pump (ejection fraction 40% or less) caused by blocked arteries. Half will get artery-opening stents plus standard heart medications, and the other half will get medications alone. The goal is to see which approac…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 09:41 UTC
-
New pump mode may help heart patients during tricky surgery
Disease control Not yet recruitingThis study tests two settings on a temporary heart pump used during a high-risk procedure to open blocked arteries in people with weak hearts. Half of the 50 participants will get an automatic pump setting that adjusts flow as needed, while the other half gets a fixed lower flow.…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Rayyan Hemetsberger • Aim: Disease control
Last updated May 26, 2026 09:32 UTC
-
New device zaps lung arteries to ease heart failure
Disease control Not yet recruitingThis study tests a device that uses radiofrequency energy to calm overactive nerves in the lung arteries of people with heart failure and a specific type of high blood pressure in the lungs. About 750 adults who are stable on heart failure medications will either get the procedur…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Pulnovo Medical, Inc. • Aim: Disease control
Last updated May 26, 2026 09:31 UTC
-
One pill to rule them all? new trial combines 4 heart drugs for easier treatment
Disease control Not yet recruitingThis study tests whether a single pill containing four standard heart failure medications can help people in Sri Lanka better manage their condition. About 1,656 adults with heart failure and reduced pumping function will either receive the combination pill or usual care. The goa…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 09:29 UTC
-
Major trial to determine best heart procedure for dual heart conditions
Disease control Not yet recruitingThis study looks at two different heart procedures for people who have both atrial fibrillation (an irregular heartbeat) and heart failure (a weakened heart pump). The goal is to see which approach—catheter ablation to restore normal rhythm or a pacemaker plus ablation to control…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE4 • Sponsor: University of British Columbia • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Can a blood pressure pill unlock life-saving heart failure treatments?
Disease control Not yet recruitingThis study tests if midodrine, a drug that raises blood pressure, can help people with heart failure and low blood pressure tolerate standard heart failure medications. About 56 adults with weak hearts and low blood pressure will be randomly assigned to get midodrine or usual car…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE2, PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 19, 2026 11:59 UTC